Cooper Companies (The) (COO) competitors & alternatives
Health Care · NASDAQ
Cooper Companies (The) (COO)'s top competitors and alternatives — its most similar public companies — include Johnson & Johnson (JNJ), STAAR SURGICAL (STAA), Boston Scientific (BSX), Zimmer Biomet (ZBH), Organon & Co. (OGN), GLAUKOS CORP (GKOS), RXSIGHT INC (RXST), SIGHT SCIENCES INC (SGHT), WARBY PARKER INC CLASS A (WRBY), NATIONAL VISION HOLDINGS INC (EYE), LENZ THERAPEUTICS INC (LENZ) and TARSUS PHARMACEUTICALS INC (TARS). These are Cooper Companies (The)'s closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top COO competitors & alternatives
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$255.63 (as of 2026-07-22) · market cap $614.6B
-
STAAR SURGICALSTAAHealth Care
STAAR Surgical designs and manufactures implantable collamer lenses (ICLs) for refractive vision correction, offering reversible alternatives to corneal…
$24.71 (as of 2026-07-22) · market cap $1.2B
-
Boston ScientificBSXHealth Care
Boston Scientific is a leading medical technology company delivering minimally invasive interventional solutions to improve patient health across diverse…
$42.97 (as of 2026-07-22) · market cap $63.7B
-
Zimmer BiometZBHHealth Care
A global leader in musculoskeletal healthcare, providing a comprehensive portfolio of reconstructive implants, sports medicine, and trauma technologies to…
$88.68 (as of 2026-07-22) · market cap $17.5B
-
Organon & Co.OGNHealth Care
A diversified pharmaceutical company spun from Merck focusing on established branded medicines and medical devices for women's health, infectious disease, and…
$13.52 (as of 2026-07-22) · market cap $3.6B
-
GLAUKOS CORPGKOSHealth Care
Glaukos is a specialized ophthalmic company transforming eye care through innovative Micro-Invasive Glaucoma Surgery devices and proprietary sustained-release…
$152.86 (as of 2026-07-22) · market cap $8.9B
-
RXSIGHT INCRXSTHealth Care
RxSight is the only company commercializing light-adjustable intraocular lenses that let surgeons customize patient vision after cataract surgery, eliminating…
$5.39 (as of 2026-07-22) · market cap $223M
-
SIGHT SCIENCES INCSGHTHealth Care
Sight Sciences develops minimally invasive interventional devices for glaucoma and dry eye, targeting ophthalmology markets through reimbursement-focused…
$5.03 (as of 2026-07-22) · market cap $274M
-
WARBY PARKER INC CLASS AWRBYConsumer Discretionary
A mission-driven, direct-to-consumer eyewear and eye care brand that combines designer-quality glasses, telehealth vision services, and retail stores to make…
$24.55 (as of 2026-07-22) · market cap $3.2B
-
NATIONAL VISION HOLDINGS INCEYEConsumer Discretionary
National Vision is the largest value-focused optical retailer in the U.S., operating 1,250 stores and integrating remote telehealth eye care to serve…
$19.82 (as of 2026-07-22) · market cap $1.6B
-
LENZ THERAPEUTICS INCLENZHealth Care
LENZ Therapeutics is a commercial-stage ophthalmic company that developed VIZZ, the first FDA-approved, once-daily aceclidine-based eye drop for the treatment…
$5.34 (as of 2026-07-22) · market cap $167M
-
TARSUS PHARMACEUTICALS INCTARSHealth Care
Tarsus Pharmaceuticals commercializes XDEMVY, the first FDA-approved treatment for Demodex blepharitis, with a pipeline of lotilaner-based therapies for ocular…
$57.58 (as of 2026-07-22) · market cap $2.5B
Not quite? Describe exactly what you want →
Peers are Cooper Companies (The)'s closest public companies by shared sub-industry, sector and business themes. See the full profile: Cooper Companies (The) (COO).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.